Buy Aurobindo Pharma, target price Rs 1710: JM Financial
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2024.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 88007.98 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Export Incentives and Scrap for the year ending 31-Mar-2024.
Financials
For the quarter ended 30-06-2024, the company reported a Consolidated Total Income of Rs 7787.95 Crore, up .94 % from last quarter Total Income of Rs 7715.77 Crore and up 11.79 % from last year same quarter Total Income of Rs 6966.85 Crore. Company reported net profit after tax of Rs 919.61 Crore in latest quarter.
Promoters held 51.8 per cent stake in the company as of 30-Jun-2024, while FIIs owned 16.73 per cent, DIIs 24.77 per cent.
Download ET Markets APP